AFFYIMMUNE THERAPEUTICS Trademark

Trademark Overview

On Friday, March 24, 2017, a trademark application was filed for AFFYIMMUNE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AFFYIMMUNE THERAPEUTICS trademark a serial number of 87385386. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, December 7, 2019. This trademark is owned by AffyImmune Therapeutics, Inc.. The AFFYIMMUNE THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

cells for medical or clinical use; kits comprised of cells and pharmaceuticals for medical or clinical use; pharmaceutical compositions for the treatment of cancer and for immunotherapy; biological compositions for the treatment of cancer and for immunotherapy; cellular immunotherapy compositions, namely, compositions, namely, engineered chimeric antigen receptors (CARs) and t-cell receptors (TCRs)
affyimmune therapeutics

General Information

Serial Number87385386
Word MarkAFFYIMMUNE THERAPEUTICS
Filing DateFriday, March 24, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, December 7, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and Servicescells for medical or clinical use; kits comprised of cells and pharmaceuticals for medical or clinical use; pharmaceutical compositions for the treatment of cancer and for immunotherapy; biological compositions for the treatment of cancer and for immunotherapy; cellular immunotherapy compositions, namely, compositions, namely, engineered chimeric antigen receptors (CARs) and t-cell receptors (TCRs)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 30, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAffyImmune Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNatick, MA 01760

Trademark Events

Event DateEvent Description
Monday, December 9, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, December 7, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, May 15, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, May 15, 2019FINAL REFUSAL E-MAILED
Wednesday, May 15, 2019FINAL REFUSAL WRITTEN
Wednesday, April 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 2, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 2, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 20, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 20, 2019NON-FINAL ACTION E-MAILED
Wednesday, February 20, 2019NON-FINAL ACTION WRITTEN
Thursday, November 29, 2018LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, May 24, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, November 24, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, November 24, 2017LETTER OF SUSPENSION E-MAILED
Friday, November 24, 2017SUSPENSION LETTER WRITTEN
Monday, October 16, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 16, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 11, 2017ASSIGNED TO LIE
Thursday, September 28, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 25, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 25, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 17, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, June 17, 2017NON-FINAL ACTION E-MAILED
Saturday, June 17, 2017NON-FINAL ACTION WRITTEN
Friday, June 16, 2017ASSIGNED TO EXAMINER
Thursday, March 30, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 28, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics affyimmune compositions immunotherapy cancer cells clinical namely treatment medical receptors tcrs